Lucia Languino

Prof

Thomas Jefferson University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Lucia Languino is a faculty member at Thomas Jefferson University in the United States. Her research focuses on the role of extracellular vesicles in cancer biology, particularly in prostate cancer, antitumor immunity, and metabolic reprogramming. Recent publications highlight her work on integrin expression in cancer progression and novel therapeutic vulnerabilities associated with cancer cell biology.

Articles (11)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

michela perego

Research Assistant Professor

The Wistar Institute

UNITED STATES

View details

Valentina Vaira

University of Milan

ITALY

View details

Ashley Russell

Assistant Professor of Biochemistry and Molecular Biology

Penn State Behrend

UNITED STATES

View details

James Mark

Assistant Professor

Thomas Jefferson University

UNITED STATES

View details

Aaron Goldman

Assistant Professor

The Wistar Institute

UNITED STATES

View details

Matthew Schiewer

Assistant Professor

Thomas Jefferson University

UNITED STATES

View details

Pyung hun Park

Thomas Jefferson University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lucia Languino

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor Immunity

Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability

STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer

Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells

The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer

A cancer ubiquitome landscape identifies metabolic reprogramming as target of Parkin tumor suppression

Differential expression of avß3 and avß6 integrins in prostate cancer progression

IFIT3 (interferon induced protein with tetratricopeptide repeats 3) modulates STAT1 expression in small extracellular vesicles

Announcing the ISEV2020 special achievement award recipients: Andrew Hill and Edit Buzás; and the recipient of the ISEV2020 special education award: Carolina Soekmadji

Hitting the Bullseye: Are extracellular vesicles on target?

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

Collaborators (7)

michela perego

Valentina Vaira

Ashley Russell

James Mark

Aaron Goldman

Matthew Schiewer

Pyung hun Park

Make your next move.